News & Updates
Inside Innovation
The latest news and advances from the world's most exciting life science cluster.
Cardiac Dimensions secures $53M bringing a new dimension to heart failure treatment
Cardiac Dimensions, a leader in minimally invasive heart failure treatments, raised $53 million in Series E funding to advance its Carillon Mitral Contour System for
GeekWire Awards: Health Innovation of the Year field is dominated by finalists battling cancer
LSW members Archon Biosciences, Fred Hutch Cancer Center, Talus Bioscience and Umoja Biopharma were named as finalists for GeekWire’s Health Innovation of the Year Award.
Shingles vaccine maker Curevo lands $110M, adds biotech vets to board
Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B round. Curevo’s efforts target shingles, a painful condition
Omeros Corporation Receives Commitment of Over $4 Million from NIDA for Further Development of the Company’s OMS527 Program to Treat Cocaine Use Disorder
Omeros received $4.02 million in funding from the National Institute on Drug Abuse (NIDA) for clinical development of its OMS527 program to treat cocaine use
AGC Biologics Honored for Excellence in Development and Manufacturing
AGC Biologics received two awards from the annual CDMO Leadership Awards, sponsored by Outsourced Pharma and Life Science Connect. “We are honored that our customers
Science Firsthand: Predicting new possibilities in drug discovery
Predictive technologies are transforming R&D, accelerating the development of high-quality medicines, and bringing life-changing treatments to patients faster than ever before. In the latest episode
In buying cell therapy partner 2seventy bio for $286M, BMS takes full control of Abecma
Bristol Myers Squibb (BMS) has agreed to buy out 2seventy bio for a total equity value of about $286 million. The two companies had previously
Bothell medical tech company eyes local expansion after $28 million raise
After raising $28.3 million, Bothell-based VerAvanti is expanding its footprint in the Seattle region. Founded in 2013, VerAvanti specializes in imaging solutions and is developing
Seattle Hub for Synthetic Biology lands $10M to support ‘DNA Typewriter’ technology
The Seattle Hub for Synthetic Biology, a collaboration between the Allen Institute, the Chan Zuckerberg Initiative and the University of Washington, received a $10 million
Seattle biotech launches with $187 million for cancer treatments
Callio Therapeutics, which has dual headquarters in Seattle and Singapore, launched on Monday, March 3, with a $187 million Series A round. Specializing in cancer
Spokane startup that gives labs a green seal of approval raises $5M
Impact Laboratories, a Spokane-based startup verifying the environmental bona fides of approximately 3,800 labs worldwide, announced nearly $5 million in funding to expand its efforts.
Seed grant funding awarded to six collaborative projects
Washington State University Health Sciences and Seattle Children’s Research Institute awarded six collaborative projects $300,000 in seed grant funding, following an inaugural joint symposium between